West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
302.19
-3.97 (-1.30%)
Apr 27, 2026, 4:00 PM EDT - Market closed

WST Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2213,0742,8932,9502,8872,832
Revenue Growth (YoY)
11.23%6.25%-1.92%2.18%1.95%31.89%
Cost of Revenue
2,0531,9701,8951,8211,7511,656
Gross Profit
1,1691,104998.51,1291,1361,176
Selling, General & Admin
405.1393.6338.5353.4316.9362.8
Research & Development
73.874.369.168.458.552.8
Other Operating Expenses
34.651.22131.426.87.9
Total Operating Expenses
513.5519.1428.6453.2402.2423.5
Operating Income
655584.9569.9676734752.3
Interest Income
2717.519.6285.11
Interest Expense
-2.2-0.5-3-9-7.9-8.2
Other Non-Operating Income (Expense)
-1-1-13-51.33.8
Total Non-Operating Income (Expense)
23.81615.622-54.1-3.4
Pretax Income
678.8600.9585.5698679.9748.9
Provision for Income Taxes
142.2121.6107.5122.3114.7107.2
Net Income
557.1508.1507.4611.1606.6681.9
Minority Interest in Earnings
-14.4-14.4-14.7-17.7-20.7-20.1
Net Income to Common
557.1508.1507.4611.1606.6681.9
Net Income Growth
15.82%0.14%-16.97%0.74%-11.04%87.54%
Shares Outstanding (Basic)
727273747474
Shares Outstanding (Diluted)
737374757676
Shares Change (YoY)
-1.09%-1.36%-2.13%-0.66%-0.66%0.66%
EPS (Basic)
7.526.836.757.987.878.89
EPS (Diluted)
7.486.796.697.887.738.67
EPS Growth
17.42%1.49%-15.10%1.94%-10.84%89.72%
Shares Outstanding
70.97272.373.574.174.2
Free Cash Flow
458468.9276.4414.5439.4330.6
Free Cash Flow Growth
-2.33%69.64%-33.32%-5.67%32.91%10.90%
Free Cash Flow Per Share
6.316.453.755.505.804.33
Dividends Per Share
0.8600.8500.8100.7700.7300.690
Dividend Growth
1.18%4.94%5.20%5.48%5.80%6.15%
Gross Margin
36.28%35.91%34.51%38.28%39.36%41.52%
Operating Margin
20.34%19.03%19.70%22.92%25.43%26.57%
Profit Margin
16.85%16.06%17.03%20.12%20.30%23.37%
FCF Margin
14.22%15.25%9.55%14.05%15.22%11.68%
EBITDA
831.6756.3725.3813.3854.6874.6
EBITDA Margin
25.82%24.60%25.07%27.57%29.60%30.89%
EBIT
655584.9569.9676734752.3
EBIT Margin
20.34%19.03%19.70%22.92%25.43%26.57%
Effective Tax Rate
20.95%20.24%18.36%17.52%16.87%14.31%
Updated Apr 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q